New Northwestern Medicine research is believed to have uncovered a novel therapeutic target for the number one genetic killer of toddlers in the developed world. Yong-Chao Ma, PhD, assistant professor in pediatrics, neurology, and physiology, is also working to uncover the potential of a new target in the fight against Parkinson’s disease.
Browsing: Roger Anderson
Started by Dean Eric G. Neilson, MD, the annual luncheon celebrating Feinberg’s endowed professors serves as a way to thank and honor these faculty members for their accomplishments and contributions to science, education, and research.
An innovative year-long pilot program has laid the foundation for training focused on elevating community-engaged research teams to the level of National Institutes of Health funding.
Jeffrey Barsuk, MD, MS, presented information about the central line insertion simulation training program he developed and implemented with Diane Wayne, MD, to a national audience during an AAMC webinar.
To commemorate the Martin Luther King Jr. holiday, members of the Chicago campus DREAM Committee hosted two panel discussions, a movie screening, and reception in an effort to connect the legacy of Dr. King to today’s social justice challenges through critical analysis and reflection.
One of 11 “death-by-cancer” genes, the role of ubiquitin-specific peptidase 22 in the development of colon and ovarian cancer has been revealed for the first time.
As the NHL season is set to begin, Michael Terry, MD, associate professor in orthopaedic surgery and team physician for the Chicago Blackhawks, prepares for the unexpected, on the ice and off.
Lisa VanWagner, a fellow in gastroenterology and hepatology, will be working alongside mentors Anton Skaro, MD, PhD, assistant professor of organ transplantation, Michael Abecassis, MD, MBA, director of the Comprehensive Transplant Center, and Donald Lloyd-Jones, MD, ScM, director of the Northwestern University Clinical and Translational Sciences Institute, to study orthotopic liver transplantation and cardiovascular disease.
The only degree of its kind in the country, the joint Doctor of Physical Therapy and PhD in Engineering program marries two disciplines for one clear benefit: improved rehabilitation therapies and technologies for patients with movement disorders.